BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26362361)

  • 1. The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.
    Marusich JA; Antonazzo KR; Blough BE; Brandt SD; Kavanagh PV; Partilla JS; Baumann MH
    Neuropharmacology; 2016 Feb; 101():68-75. PubMed ID: 26362361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
    Brandt SD; Walters HM; Partilla JS; Blough BE; Kavanagh PV; Baumann MH
    Psychopharmacology (Berl); 2020 Dec; 237(12):3703-3714. PubMed ID: 32875347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.
    Maier J; Mayer FP; Luethi D; Holy M; Jäntsch K; Reither H; Hirtler L; Hoener MC; Liechti ME; Pifl C; Brandt SD; Sitte HH
    Neuropharmacology; 2018 Aug; 138():282-291. PubMed ID: 29908239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eutylone and Its Structural Isomers Interact with Monoamine Transporters and Induce Locomotor Stimulation.
    Glatfelter GC; Walther D; Evans-Brown M; Baumann MH
    ACS Chem Neurosci; 2021 Apr; 12(7):1170-1177. PubMed ID: 33689284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of mephedrone analogs and related new psychoactive substances.
    Luethi D; Kolaczynska KE; Docci L; Krähenbühl S; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):4-12. PubMed ID: 28755886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
    Simmler LD; Liechti ME
    Handb Exp Pharmacol; 2018; 252():143-164. PubMed ID: 29633178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
    Rickli A; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones.
    Fitzgerald LR; Gannon BM; Walther D; Landavazo A; Hiranita T; Blough BE; Baumann MH; Fantegrossi WE
    Neuropharmacology; 2024 Mar; 245():109827. PubMed ID: 38154512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
    Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV
    Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability.
    Solis E; Partilla JS; Sakloth F; Ruchala I; Schwienteck KL; De Felice LJ; Eltit JM; Glennon RA; Negus SS; Baumann MH
    Neuropsychopharmacology; 2017 Sep; 42(10):1950-1961. PubMed ID: 28530234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of Drugs Used as Stimulants.
    Docherty JR; Alsufyani HA
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S53-S69. PubMed ID: 34396557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-Alkyl-4-Methylamphetamine Optical Isomers on Plasma Membrane Monoamine Transporters and Abuse-Related Behavior.
    Battisti UM; Sitta R; Harris A; Sakloth F; Walther D; Ruchala I; Negus SS; Baumann MH; Glennon RA; Eltit JM
    ACS Chem Neurosci; 2018 Jul; 9(7):1829-1839. PubMed ID: 29697951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice.
    Powell SB; Lehmann-Masten VD; Paulus MP; Gainetdinov RR; Caron MG; Geyer MA
    Psychopharmacology (Berl); 2004 May; 173(3-4):310-7. PubMed ID: 14747902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain.
    Kindlundh-Högberg AM; Schiöth HB; Svenningsson P
    Neurotoxicology; 2007 Nov; 28(6):1158-69. PubMed ID: 17692920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.
    Luethi D; Kolaczynska KE; Walter M; Suzuki M; Rice KC; Blough BE; Hoener MC; Baumann MH; Liechti ME
    J Psychopharmacol; 2019 Jul; 33(7):831-841. PubMed ID: 31038382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Custodio RJ; Woo T; Seo JW; Jang CG; Yang JS; Yoon YM; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2018 Apr; 341():122-128. PubMed ID: 29288746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.
    Yubero-Lahoz S; Ayestas MA; Blough BE; Partilla JS; Rothman RB; de la Torre R; Baumann MH
    Eur J Pharmacol; 2012 Jan; 674(2-3):337-44. PubMed ID: 22079770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.